DSIP (Delta Sleep Inducing Peptide) is a peptide that has been studied for its potential relationship to sleep regulation and neuroendocrine signaling. Research in humans remains limited, and its effects on sleep have not been established conclusively. Our healthcare provider will determine whether DSIP is an appropriate option based on an individual medical evaluation.
Delta Sleep Inducing Peptide is administered by subcutaneous injection at night according to the dosing schedule prescribed by our healthcare provider. The supplied protocol indicates 100–200 mcg per injection for a treatment period of approximately 4–8 weeks. Do not change the dose, frequency, or duration unless instructed by our healthcare provider.
Q: What exactly is DSIP?
A: Delta Sleep Inducing Peptide is a small synthetic peptide that has been studied for several biological effects, including possible involvement in sleep and neuroendocrine regulation.
Q: Does DSIP treat insomnia?
A: DSIP should not be considered an established treatment for insomnia. Human research is limited and has produced mixed results, so individual outcomes cannot be predicted.
Q: What does the research say about sleep?
A: Small human studies have reported changes in certain measures of sleep, while other research found limited clinical significance. More evidence is needed to establish its effectiveness for sleep-related conditions.
Q: How is DSIP administered?
A: DSIP is given by subcutaneous injection according to the individualized instructions provided by our healthcare provider. The prescribed dose and treatment period should be followed exactly.
Q: How long is a DSIP treatment plan?
A: The supplied protocol uses an initial period of approximately 4–8 weeks. Our healthcare provider will determine the appropriate duration and whether treatment should continue.
Q: Is DSIP FDA-approved for sleep?
A: No. DSIP is not an FDA-approved treatment for insomnia or other sleep disorders. Its potential uses remain investigational.
Physician-led, prescription-based care for weight, hormone, skin, and longevity health.
© 2026 Eternelle Health. All treatments are prescribed by a licensed provider and dispensed by a licensed U.S. pharmacy.
Privacy · Terms
Eternelle Health provides administrative, technology, and care-coordination services that support access to telehealth services. Eternelle Health does not practice medicine and does not manufacture, compound, dispense, diagnose, or prescribe medications. Medical consultations, diagnoses, treatment decisions, and prescriptions are provided solely by independently licensed healthcare providers based on their professional judgment. When clinically appropriate, prescriptions may be sent to licensed U.S. pharmacies for dispensing or patient-specific compounding and fulfillment.
Some medications offered through affiliated healthcare providers may be compounded. Compounded medications are not FDA-approved. The FDA does not review compounded medications for safety, effectiveness, or quality before they are marketed. Medication availability, treatment eligibility, and prescribing decisions vary based on individual patient circumstances, provider discretion, pharmacy availability and policy, applicable state and federal law, and current regulatory guidance. Individual results and experiences may vary, and no specific outcome is guaranteed.
Eternelle Health does not provide emergency medical services. If you are experiencing a medical emergency, call 911 or seek immediate medical attention. Services are available only to individuals 18 years of age or older and may not be available in all states.
© 2026 Eternelle Health. All rights reserved.
Orange County, CA
(Virtual Services Nationwide)
(949) 990-4490
hello@eternellehealth.com
Oops! We could not locate your form.
Orange County, CA
(Virtual Services Nationwide)
(949) 990-4490
hello@eternellehealth.com
